• Sun. Oct 25th, 2020

Successful Remote Installation of TRUFORMA™ Permits Validation and Pilot Program Development Throughout COVID-19 Restrictions

Successful Remote Installation of TRUFORMA™ Permits Validation and Pilot Program Development Throughout COVID-19 Restrictions
ANN ARBOR, Mich., July 21, 2020 (GLOBE NEWSWIRE) — Zomedica Prescribed pills Corp. (NYSE American: ZOM), (“Zomedica” or the “Firm”), a veterinary properly being company, announced this day that, in step with the COVID-19 disaster, it successfully applied its first fully remote installations of TRUFORMA™, the Firm’s inaugural level-of-care diagnostic instrument. Remote set up has enabled Zomedica to proceed with validation sorting out with its clinical College of Veterinary Medication partners at Auburn, Mississippi Sing, and Purdue Universities.

TRUFORMA’s easy affect and intuitive individual skills facilitates entirely remote set up of the instrument and subsequent virtual operational coaching of the TRUFORMA platform. Validation sorting out and a deliberate pilot program are not anticipated to be delayed by any social distancing mandates.

Zomedica also not too long ago performed verification of canines cortisol for exhaust with its TRUFORMA platform, and shall be including that assay to its ongoing validation research, which already encompass canines and feline complete T4 (“tT4”) and canines and feline TSH (thyroid stimulating hormone) assays.  The Firm intends to continue to add extra assays to its rising TRUFORMA platform.  

Related Post